195 related articles for article (PubMed ID: 23708199)
21. Occurrence and removal of pharmaceuticals and hormones through drinking water treatment.
Huerta-Fontela M; Galceran MT; Ventura F
Water Res; 2011 Jan; 45(3):1432-42. PubMed ID: 21122885
[TBL] [Abstract][Full Text] [Related]
22. The removal of microorganisms and organic micropollutants from wastewater during infiltration to aquifers after irrigation of farmland in the Tula Valley, Mexico.
Chávez A; Maya C; Gibson R; Jiménez B
Environ Pollut; 2011 May; 159(5):1354-62. PubMed ID: 21316131
[TBL] [Abstract][Full Text] [Related]
23. Conventional drinking water treatment and direct biofiltration for the removal of pharmaceuticals and artificial sweeteners: A pilot-scale approach.
McKie MJ; Andrews SA; Andrews RC
Sci Total Environ; 2016 Feb; 544():10-7. PubMed ID: 26657244
[TBL] [Abstract][Full Text] [Related]
24. Removal of selected pharmaceuticals by chlorination, coagulation-sedimentation and powdered activated carbon treatment.
Simazaki D; Fujiwara J; Manabe S; Matsuda M; Asami M; Kunikane S
Water Sci Technol; 2008; 58(5):1129-35. PubMed ID: 18824814
[TBL] [Abstract][Full Text] [Related]
25. Priority organic micropollutants in water sources in Flanders and the Netherlands and assessment of removal possibilities with nanofiltration.
Verliefde A; Cornelissen E; Amy G; Van der Bruggen B; van Dijk H
Environ Pollut; 2007 Mar; 146(1):281-9. PubMed ID: 16965844
[TBL] [Abstract][Full Text] [Related]
26. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
Ying GG; Kookana RS; Kolpin DW
J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
[TBL] [Abstract][Full Text] [Related]
27. Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents--modeling versus measurements.
Heberer T; Feldmann D
J Hazard Mater; 2005 Jul; 122(3):211-8. PubMed ID: 15967276
[TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical retention mechanisms by nanofiltration membranes.
Nghiem LD; Schäfer AI; Elimelech M
Environ Sci Technol; 2005 Oct; 39(19):7698-705. PubMed ID: 16245847
[TBL] [Abstract][Full Text] [Related]
29. Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac.
Zwiener C; Frimmel FH
Sci Total Environ; 2003 Jun; 309(1-3):201-11. PubMed ID: 12798104
[TBL] [Abstract][Full Text] [Related]
30. Removal of acidic pharmaceuticals within a nitrifying recirculating biofilter.
Krkošek WH; Payne SJ; Gagnon GA
J Hazard Mater; 2014 May; 273():85-93. PubMed ID: 24727009
[TBL] [Abstract][Full Text] [Related]
31. Photo-regenerable multi-walled carbon nanotube membranes for the removal of pharmaceutical micropollutants from water.
Zaib Q; Mansoor B; Ahmad F
Environ Sci Process Impacts; 2013 Aug; 15(8):1582-9. PubMed ID: 23811952
[TBL] [Abstract][Full Text] [Related]
32. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
[TBL] [Abstract][Full Text] [Related]
33. Arsenate removal using a combination treatment of precipitation and nanofiltration.
Chang FF; Liu WJ
Water Sci Technol; 2012; 65(2):296-302. PubMed ID: 22233908
[TBL] [Abstract][Full Text] [Related]
34. Emerging pollutants in sewage, surface and drinking water in Galicia (NW Spain).
Rodil R; Quintana JB; Concha-Graña E; López-Mahía P; Muniategui-Lorenzo S; Prada-Rodríguez D
Chemosphere; 2012 Mar; 86(10):1040-9. PubMed ID: 22189380
[TBL] [Abstract][Full Text] [Related]
35. Strategies for the removal of halides from drinking water sources, and their applicability in disinfection by-product minimisation: a critical review.
Watson K; Farré MJ; Knight N
J Environ Manage; 2012 Nov; 110():276-98. PubMed ID: 22810000
[TBL] [Abstract][Full Text] [Related]
36. Human pharmaceuticals in wastewaters from urbanized areas of Argentina.
Elorriaga Y; Marino DJ; Carriquiriborde P; Ronco AE
Bull Environ Contam Toxicol; 2013 Apr; 90(4):397-400. PubMed ID: 23229304
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant.
Clara M; Strenn B; Ausserleitner M; Kreuzinger N
Water Sci Technol; 2004; 50(5):29-36. PubMed ID: 15497826
[TBL] [Abstract][Full Text] [Related]
38. Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada.
Hua W; Bennett ER; Letcher RJ
Water Res; 2006 Jul; 40(12):2259-66. PubMed ID: 16777173
[TBL] [Abstract][Full Text] [Related]
39. Potential of pulsed corona discharges generated in water for the degradation of persistent pharmaceutical residues.
Banaschik R; Lukes P; Jablonowski H; Hammer MU; Weltmann KD; Kolb JF
Water Res; 2015 Nov; 84():127-35. PubMed ID: 26218466
[TBL] [Abstract][Full Text] [Related]
40. Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters.
Taheran M; Brar SK; Verma M; Surampalli RY; Zhang TC; Valero JR
Sci Total Environ; 2016 Mar; 547():60-77. PubMed ID: 26789358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
